Neogen Corp (NEOG)
14.98
+0.40
(+2.74%)
USD |
NASDAQ |
Nov 22, 16:00
14.97
-0.01
(-0.07%)
After-Hours: 20:00
Neogen Revenue (Quarterly): 216.96M for Aug. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 216.96M |
| May 31, 2024 | 236.79M |
| February 29, 2024 | 228.81M |
| November 30, 2023 | 229.63M |
| August 31, 2023 | 228.99M |
| May 31, 2023 | 241.81M |
| February 28, 2023 | 218.26M |
| November 30, 2022 | 230.03M |
| August 31, 2022 | 132.35M |
| May 31, 2022 | 140.09M |
| February 28, 2022 | 128.24M |
| November 30, 2021 | 130.52M |
| August 31, 2021 | 128.30M |
| May 31, 2021 | 127.42M |
| February 28, 2021 | 116.71M |
| November 30, 2020 | 115.00M |
| August 31, 2020 | 109.32M |
| May 31, 2020 | 109.07M |
| February 29, 2020 | 99.87M |
| November 30, 2019 | 107.80M |
| August 31, 2019 | 101.42M |
| May 31, 2019 | 109.76M |
| February 28, 2019 | 97.70M |
| November 30, 2018 | 107.10M |
| August 31, 2018 | 99.63M |
| Date | Value |
|---|---|
| May 31, 2018 | 108.12M |
| February 28, 2018 | 94.90M |
| November 30, 2017 | 100.70M |
| August 31, 2017 | 94.21M |
| May 31, 2017 | 95.53M |
| February 28, 2017 | 88.38M |
| November 30, 2016 | 90.72M |
| August 31, 2016 | 83.64M |
| May 31, 2016 | 90.08M |
| February 29, 2016 | 76.72M |
| November 30, 2015 | 79.61M |
| August 31, 2015 | 74.86M |
| May 31, 2015 | 78.61M |
| February 28, 2015 | 68.41M |
| November 30, 2014 | 68.46M |
| August 31, 2014 | 67.60M |
| May 31, 2014 | 67.26M |
| February 28, 2014 | 62.00M |
| November 30, 2013 | 59.60M |
| August 31, 2013 | 58.55M |
| May 31, 2013 | 56.01M |
| February 28, 2013 | 51.06M |
| November 30, 2012 | 50.74M |
| August 31, 2012 | 49.73M |
| May 31, 2012 | 48.54M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
99.87M
Minimum
Feb 2020
241.81M
Maximum
May 2023
163.80M
Average
131.43M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Biogen Inc | 2.466B |
| Dynavax Technologies Corp | 80.63M |
| Repligen Corp | 154.87M |
| Xencor Inc | 10.71M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.61M |
| Total Expenses (Quarterly) | 214.71M |
| EPS Diluted (Quarterly) | -0.06 |
| Enterprise Value | 4.015B |
| Gross Profit Margin (Quarterly) | 48.36% |
| Profit Margin (Quarterly) | -5.81% |
| Earnings Yield | -0.77% |
| Operating Earnings Yield | 1.29% |
| Normalized Earnings Yield | -0.6818 |